Merit Medical Systems, Inc. Stock

Equities

MMSI

US5898891040

Medical Equipment, Supplies & Distribution

Delayed Nasdaq 03:48:49 2024-05-23 pm EDT 5-day change 1st Jan Change
80.88 USD -1.53% Intraday chart for Merit Medical Systems, Inc. -1.67% +6.49%
Sales 2024 * 1.32B Sales 2025 * 1.4B Capitalization 4.77B
Net income 2024 * 130M Net income 2025 * 152M EV / Sales 2024 * 3.61 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 3.42 x
P/E ratio 2024 *
36.8 x
P/E ratio 2025 *
31.7 x
Employees 6,950
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97.53%
More Fundamentals * Assessed data
Dynamic Chart
Merit Medical Elects Silvia M. Perez as New Director CI
Merit Medical Systems Appoints Joe Wright as President MT
Merit Medical Systems, Inc. Announces Appointment of Joe Wright as President CI
Merit Medical Gets FDA Clearance for Siege Vascular Plug, Launches Bearing Express Prefilled Syringe in US, Australia MT
Merit Medical Systems, Inc. Announce US Food and Drug Administration 510(K) Clearance for its Siege Vascular Plug and Launches its Bearing nsPVA Express Prefilled Syringe in the United States and Australia CI
Barrington Raises Adjusts Price Target on Merit Medical Systems to $100 From $98, Maintains Outperform Rating MT
Transcript : Merit Medical Systems, Inc., Q1 2024 Earnings Call, Apr 30, 2024
(MMSI) MERIT MEDICAL SYSTEMS Sees Fiscal Year 2024 EPS Range $3.28 - $3.35 MT
Earnings Flash (MMSI) MERIT MEDICAL SYSTEMS Reports Q1 Revenue $323.5M, vs. Street Est of $315.9M MT
Earnings Flash (MMSI) MERIT MEDICAL SYSTEMS Reports Q1 EPS $0.77, vs. Street Est of $0.72 MT
Merit Medical Systems, Inc. Reaffirms Sales Guidance for the Year Ending December 31, 2024 CI
Merit Medical Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Merit Medical Launches Micro ACE Micro-Access System in US MT
Merit Medical Systems, Inc. Launches the Micro Ace Advanced Micro-Access System CI
Merit Medical Systems Insider Sold Shares Worth $479,182, According to a Recent SEC Filing MT
More news
1 day-1.00%
1 week-1.21%
Current month+9.67%
1 month+9.55%
3 months+1.82%
6 months+12.37%
Current year+6.98%
More quotes
1 week
81.14
Extreme 81.14
83.24
1 month
72.81
Extreme 72.81
84.04
Current year
70.70
Extreme 70.7
84.04
1 year
62.58
Extreme 62.58
85.62
3 years
50.46
Extreme 50.46
85.62
5 years
19.50
Extreme 19.5
85.62
10 years
11.41
Extreme 11.41
85.62
More quotes
Managers TitleAgeSince
Chief Executive Officer 74 87-06-30
Director of Finance/CFO 46 09-11-30
President 54 04-12-31
Members of the board TitleAgeSince
Chief Executive Officer 74 87-06-30
Director/Board Member 60 22-04-30
Director/Board Member 63 20-06-21
More insiders
Date Price Change Volume
24-05-23 80.88 -1.53% 156 506
24-05-22 82.14 -0.21% 253,234
24-05-21 82.31 -0.90% 520,756
24-05-20 83.06 +1.43% 250,877
24-05-17 81.89 -0.45% 287,535

Delayed Quote Nasdaq, May 23, 2024 at 10:12 am EDT

More quotes
Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
82.14 USD
Average target price
92.7 USD
Spread / Average Target
+12.86%
Consensus